Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Qian ^a   Du, Jianjun ^b   Yu, Pengfei ^a   Bai, Bin ^a   Zhao, Zhanwei ^a   Wang, Shiqi ^a   Zhu, Junjie ^a   Feng, Quanxin ^a   Gao, Yun ^c   Zhao, Qingchuan ^a   Liu, Chaoxu ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Department of Surgery   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; LEPTIN; PROTEOME; SERPINA1 PROTEIN, HUMAN; TRYPSIN;

ADOLESCENT; ADULT; AGED; ANIMAL; BLOOD; COMPLICATION; FATTY LIVER; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MIDDLE AGED; PANCREATITIS; PATHOLOGY; RAT;

ADOLESCENT; ADULT; AGED; ALPHA 1-ANTITRYPSIN; ANIMALS; FATTY LIVER; GENE EXPRESSION REGULATION; HUMANS; LEPTIN; MIDDLE AGED; PANCREATITIS; PROTEOME; RATS; TRYPSIN;

EID: 84949294632     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17833     Document Type: Article

References (60)

1. Sha, H. et al. Resveratrol suppresses microcirculatory disturbance in a rat model of severe acute pancreatitis. Cell Biochem. Biophys. 67, 1059-1065 (2013).
2. Kemppainen, E. A., Hedstrom, J. I., Puolakkainen, P. A., Haapiainen, R. K. & Stenman, U. H. Advances in the laboratory diagnostics of acute pancreatitis. Ann. Med. 30, 169-175 (1998).
3. Sawalhi, S., Al-Maramhy, H., Abdelrahman, A. I., Allah, S. E. & Al-Jubori, S. Does the presence of obesity and/or metabolic syndrome affect the course of acute pancreatitis? A prospective study. Pancreas 43, 565-570 (2014).
4. Tormey, W. P., Sabah, M. & Moore, T. M. Methadone, codeine and acute haemorrhagic necrotising pancreatitis: which came first? Forensic Sci. Int. 226, e52-53 (2013).
5. Smith, G. P. 2nd. Recognizing personhood and the right to die with dignity. J. Palliat. Care 6, 24-32 (1990).
6. Xiao, B. et al. Fatty liver in acute pancreatitis: characteristics in magnetic resonance imaging. J. Comput. Assist. Tomogr. 36, 400-405 (2012).
7. Day, C. P. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut 50, 585-588 (2002).
8. Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221-1231 (2002).
9. Lonardo, A. Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going? Dig. Dis. 17, 80-89 (1998).
10. Hilden, M., Christoffersen, P., Juhl, E. & Dalgaard, J. B. Liver histology in a'normal'population-examinations of 503 consecutive fatal traffic casualties. Scand. J. Gastroentero. 12, 593-597 (1977).
11. Tomizawa, M. et al. Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes. Biomed. Rep. 2, 633-636 (2014).
12. Ditzel, J. & Thaysen, E. H. Increased hemoglobin-oxygen affinity in patients with panreatitis associated with type I and V hyperlipoproteinemia. Adv. Exp. Med. Biol 94, 423-428 (1977).
13. Van Gossum, A., Closset, P., Noel, E., Cremer, M. & Neve, J. Deficiency in antioxidant factors in patients with alcohol-related chronic pancreatitis. Dig. Dis. Sci. 41, 1225-1231 (1996).
14. Tang, Q.-q., Su, S.-y. & Fang, M.-y. Zinc supplement modulates oxidative stress and antioxidant values in rats with severe acute pancreatitis. Biol. Trace Elem. Res. 159, 320-324 (2014).
15. Nagai, H., Henrich, H., Wunsch, P.-H., Fischbach, W. & Mossner, J. Role of pancreatic enzymes and their substrates in autodigestion of the pancreas. In vitro studies with isolated rat pancreatic acini. Gastroenterology 96, 838-847 (1989).
16. Xiao, W. Q. et al. Catalpol ameliorates sodium taurocholate-induced acute pancreatitis in rats via inhibiting activation of nuclear factor kappa B. Int. J. Mol. Sci. 15, 11957-11972 (2014).
17. Serres, F. d. & Blanco, I. Role of alpha-1 antitrypsin in human health and disease. J. Intern. Med. 276, 311-335 (2014).
18. Morgan, K. & Kalsheker, N. A. Regulation of the serine proteinase inhibitor (SERPIN) gene alpha 1-antitrypsin: a paradigm for other SERPINs. Int. J. Biochem. Cell Biol. 29, 1501-1511 (1997).
19. Xiaokaiti, Y. et al. EGCG reverses human neutrophil elastase-induced migration in A549 cells by directly binding to HNE and by regulating α 1-AT. Sci. Rep. 5, 11494 (2015)
20. Ahsan, A. et al. Alpha-1 antitrypsin, a diagnostic and prognostic marker of vernal keratoconjunctivitis. J. Clin. Diagn. Res. 8, Cc08-10 (2014).
21. Taggart, C. et al. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J. Biol. Chem. 275, 27258-27265 (2000).
22. Marwick, T. H., Cooney, P. T. & Kerlin, P. Cirrhosis and hepatocellular carcinoma in a patient with heterozygous (MZ) alpha-1-antitrypsin deficiency. Pathology 17, 649-652 (1985).
23. Karsidag, T., Tuzun, S., Kemik, A. S., Purisa, S. & Unlu, A. Alpha-1 protease inhibitor and antichymotrypsin levels in acute pancreatitis. Ulus. Travma Acil Cerrahi Derg. 18, 195-199 (2012).
24. Garcia-Hernandez, V. et al. Proteomic analysis of the soluble and the lysosomal + mitochondrial fractions from rat pancreas: Implications for cerulein-induced acute pancreatitis. Biochim. Biophys. Acta 1824, 1058-1067 (2012).
25. Andersen, J. M. et al. The ratio of trypsin-2-alpha(1)-antitrypsin to trypsinogen-1 discriminates biliary and alcohol-induced acute pancreatitis. Clin. Chem. 47, 231-236 (2001).
26. Yin, G. et al. C-reactive protein: rethinking its role in evaluating the severity of hyperlipidemic acute pancreatitis. Pancreas 43, 1323-1328 (2014).
27. Aho, H. J. & Nevalainen, T. J. Experimental pancreatitis in the rat. Ultrastructure of sodium taurocholate-induced pancreatic lesions. Scand. J. Gastroenterol. 15, 417-424 (1980).
28. Karimgani, I., Porter, K. A., Langevin, R. E. & Banks, P. A. Prognostic factors in sterile pancreatic necrosis. Gastroenterology 103, 1636-1640 (1992).
29. Mery, C. M. et al. Android fat distribution as predictor of severity in acute pancreatitis. Pancreatology 2, 543-549 (2002).
30. Gloor, B. et al. Late mortality in patients with severe acute pancreatitis. Br. J. Surg. 88, 975-979 (2001).
31. Funnell, I. C., Bornman, P. C., Weakley, S. P., Terblanche, J. & Marks, I. N. Obesity: an important prognostic factor in acute pancreatitis. Br. J. Surg. 80, 484-486 (1993).
32. De Waele, B., Vanmierlo, B., Van Nieuwenhove, Y. & Delvaux, G. Impact of body overweight and class I, II and III obesity on the outcome of acute biliary pancreatitis. Pancreas 32, 343-345 (2006).
33. Chen, S. M., Xiong, G. S. & Wu, S. M. Is obesity an indicator of complications and mortality in acute pancreatitis? An updated meta-analysis. J. Dig. Dis. 13, 244-251 (2012).
34. Martinez, J. et al. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology 4, 42-48 (2004).
35. Anderson, N. L. & Anderson, N. G. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 19, 1853-1861 (1998).
36. Bergin, D. A., Hurley, K., McElvaney, N. G. & Reeves, E. P. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent. Arch. Immunol. Ther. Exp. (Warsz.) 60, 81-97 (2012).
37. Brand, P. et al. Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency. Eur. Respir. J. 34, 354-360 (2009).
38. Grimstein, C. et al. Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model. J. Transl. Med. 9, 21, (2011).
39. Sandstrom, C. S. et al. An association between Type 2 diabetes and alpha-antitrypsin deficiency. Diabet. Med. 25, 1370-1373 (2008).
40. Knappstein, S., Ide, T., Schmidt, M. A. & Heusipp, G. Alpha 1-antitrypsin binds to and interferes with functionality of EspB from atypical and typical enteropathogenic Escherichia coli strains. Infect. Immun. 72, 4344-4350 (2004).
41. Novis, B. H., Young, G. O., Bank, S. & Marks, I. N. Chronic pancreatitis and alpha-1-antitrypsin. Lancet 2, 748-749 (1975).
42. Edmunds, S. E. & Wilkinson, M. L. Alpha 1-antitrypsin deficiency and pancreatitis in a juvenile. Aust. N. Z. J. Med.21, 345-347 (1991).
43. Rabassa, A. A., Schwartz, M. R. & Ertan, A. Alpha 1-antitrypsin deficiency and chronic pancreatitis. Dig. Dis. Sci. 40, 1997-2001 (1995).
44. Lempinen, M. et al. Sequential changes in pancreatic markers in acute pancreatitis. Scand. J. Gastroenterol. 38, 666-675 (2003).
45. Tan, X. F., Wu, S. S., Li, S. P., Chen, Z. & Chen, F. Alpha-1 antitrypsin is a potential biomarker for hepatitis B. Virol. J. 8, 274 (2011).
46. Marshall, J. B. Acute pancreatitis. A review with an emphasis on new developments. Arch. Intern. Med. 153, 1185-1198 (1993).
47. Yoshino, S. et al. Protection against high-fat diet-induced obesity in Helz2-deficient male mice due to enhanced expression of hepatic leptin receptor. Endocrinology 155, 3459-3472 (2014).
48. Mansuy-Aubert, V. et al. Imbalance between neutrophil elastase and its inhibitor alpha1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure. Cell. Metab. 17, 534-548 (2013).
49. Bergin, D. A. et al. alpha-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J. Clin. Invest. 120, 4236-4250 (2010).
50. Sabina, J. & Tobias, W. Augmentation therapy with alpha1-antitrypsin: novel perspectives. Cardiovasc. Hematol. Disord. Drug Targets 13, 90-98 (2013).
51. Ehlers, M. R. Immune-modulating effects of alpha-1 antitrypsin. Biol. Chem. 395, 1187-1193 (2014).
52. Gao, W. et al. alpha1-Antitrypsin inhibits ischemia reperfusion-induced lung injury by reducing inflammatory response and cell death. J. Heart Lung Transplant. 33, 309-315 (2014).
53. Ray, K. Liver Purified A1AT holds promise as therapy for acute liver failure. Nat. Rev. Gastroenterol. Hepatol. 11, 140 (2014).
54. Collins, C. B. et al. Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis. Inflamm. Bowel Dis. 19, 1964-1973 (2013).
55. Wilson, C. & Imrie, C. W. Effective intraperitoneal antiprotease therapy for taurocholate-induced pancreatitis in rats. Br. J. Surg. 77, 1252-1255 (1990).
56. Ohlsson, K. et al. Local administration of human pancreatic secretory trypsin inhibitor prevents the development of experimental acute pancreatitis in rats and dogs. Scand. J. Gastroenterol. 24, 693-704 (1989).
57. Fattahi, S., Kazemipour, N., Hashemi, M. & Sepehrimanesh, M. Alpha-1 antitrypsin, retinol binding protein and keratin 10 alterations in patients with psoriasis vulgaris, a proteomic approach. Iran J Basic Med Sci 17, 651-655 (2014).
58. Zeb, I. et al. Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad. Radiol. 19, 811-818 (2012).
59. Ards Definition Task Force et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307, 2526-2533 (2012).
60. Zhang, R. et al. beta-actin as a loading control for plasma-based Western blot analysis of major depressive disorder patients. Anal. Biochem. 427, 116-120 (2012).